QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online 28 February 2007
doi: 10.1242/dev.02820

This Article Figures Only Full Text Full Text (PDF) Supplementary Material OA All Versions of this Article: dev.02820v1 134/7/1443    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Moumen, A. Articles by Maina, F. Search for Related Content PubMed PubMed Citation Articles by Moumen, A. Articles by Maina, F. Social Bookmarking                         What's this?

Met acts on Mdm2 via mTOR to signal cell survival during development

¹ Developmental Biology Institute of Marseille-Luminy (IBDML) UMR 6216, CNRS-INSERM-Université de la Méditerrannée, Campus de Luminy-Case 907, 13288 Marseille Cedex 09, France.
² Dpto. Bioquimica y Biologia Molecular II, Facultad de Farmacia, Universidad Complutense, Ciudad Universitaria, 28040 Madrid, Spain.

^* Author for correspondence (e-mail: maina{at}ibdml.univ-mrs.fr)

Accepted 12 January 2007

Coordination of cell death and survival is crucial during embryogenesis and adulthood, and alteration of this balance can result in degeneration or cancer. Growth factor receptors such as Met can activate phosphatidyl-inositol-3' kinase (PI3K), a major intracellular mediator of growth and survival. PI3K can then antagonize p53-triggered cell death, but the underlying mechanisms are not fully understood. We used genetic and pharmacological approaches to uncover Met-triggered signaling pathways that regulate hepatocyte survival during embryogenesis. Here, we show that PI3K acts via mTOR (Frap1) to regulate p53 activity both in vitro and in vivo. mTOR inhibits p53 by promoting the translation of Mdm2, a negative regulator of p53. We also demonstrate that the PI3K effector Akt is required for Met-triggered Mdm2 upregulation, in addition to being necessary for the nuclear translocation of Mdm2. Inhibition of either mTOR or Mdm2 is sufficient to block cell survival induced by Hgf-Met in vitro. Moreover, in vivo inhibition of mTOR downregulates Mdm2 protein levels and induces p53-dependent apoptosis. Our studies identify a novel mechanism for Met-triggered cell survival during embryogenesis, involving translational regulation of Mdm2 by mTOR. Moreover, they reinforce mTOR as a potential drug target in cancer.

Key words: Met receptor, Hepatocyte growth factor, Receptor tyrosine kinase (RTK), Signaling in vivo, Cell survival, Mdm2, mTOR (Frap1), Mouse

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				C. Migliore, A. Petrelli, E. Ghiso, S. Corso, L. Capparuccia, A. Eramo, P. M. Comoglio, and S. Giordano MicroRNAs Impair MET-Mediated Invasive Growth Cancer Res., December 15, 2008; 68(24): 10128 - 10136. [Abstract] [Full Text] [PDF]

				S. E. Kendall, J. Najbauer, H. F. Johnston, M. Z. Metz, S. Li, M. Bowers, E. Garcia, S. U. Kim, M. E. Barish, K. S. Aboody, et al. Neural Stem Cell Targeting of Glioma Is Dependent on Phosphoinositide 3-Kinase Signaling Stem Cells, June 1, 2008; 26(6): 1575 - 1586. [Abstract] [Full Text] [PDF]

				G. del Castillo, V. M. Factor, M. Fernandez, A. Alvarez-Barrientos, I. Fabregat, S. S. Thorgeirsson, and A. Sanchez Deletion of the Met Tyrosine Kinase in Liver Progenitor Oval Cells Increases Sensitivity to Apoptosis in Vitro Am. J. Pathol., May 1, 2008; 172(5): 1238 - 1247. [Abstract] [Full Text] [PDF]